profit from every $100 of sales.
$0$100
National Health Investors
$66.02-2.61% today
-13.9% in 1 year
1-year low $63.961-year high $91.02
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $22.80 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What National Health Investors sold, what it kept, and what it did with the cash.
Sales went from $278 million in 2022 to $376 million in 2025, with $142 million of profit last year.
SalesProfit
National Health Investors handed back 72% of the cash it generated last year.
$170M
Free cash flow 2025$237M
Bought back its own shares–
Paid as dividends$170M
Cash vs. debt$20M vs. $1.2B
National Health Investors vs. similar companies
National Health Investors grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| National Health Investors | 22.8× · Fair price | ||
 Welltower | 193.7× · Very expensive | ||
 Ventas | 190.2× · Very expensive | ||
 Omega Healthcare Investors | 25.9× · Fair price | ||
 Healthpeak Properties | 207.4× · Very expensive |
AI analysis
An AI analyst reads National Health Investors's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 278 | 320 | 335 | 376 | |
| 268 | 308 | 324 | 365 | |
| 133 | 178 | 188 | 191 | |
| 179 | 260 | 264 | 276 | |
| 66 | 136 | 138 | 142 | |
| 1.48 | 3.13 | 3.13 | 3.02 | |
| 96.5% | 96.4% | 96.7% | 97.1% | |
| 47.7% | 55.8% | 56.2% | 50.7% | |
| 23.9% | 42.4% | 41.2% | 37.9% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2,507 | 2,488 | 2,614 | 2,797 |
| Cash | 19 | 22 | 24 | 20 |
| Total debt | 1,148 | 1,135 | 1,146 | 1,164 |
| Total liabilities | 1,218 | 1,214 | 1,229 | 1,257 |
| 1,270 | 1,254 | 1,366 | 1,522 | |
| 45 | 43 | 44 | 47 | |
| 3.5% | 6.3% | 6.1% | 5.7% | |
| 5.2% | 10.8% | 10.1% | 9.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 185 | 184 | 208 | 237 | |
| – | 4 | 4 | – | |
| 185 | 184 | 208 | 237 | |
| Dividends paid | 162 | 156 | 157 | 170 |
| 152 | 0 | 0 | – | |
| 9 | 5 | 4 | 6 |
Valuation
- 22.8×
- 19.5×
- 0.85
- 2.3×
- 8.6×
- 13.7×
- 15.9×
- 7.3%
- 4.4%
- 5.0%
Profitability
- 97.1%
- 50.7%
- 37.9%
- 71.8%
- 7.0%
- 4.7%
- 9.9%
- 5.1%
- 7.8%
- –
Growth
- +10.5%
- +26.8%
- +14.5%
- −3.8%
- +0.6%
Financial health
- 4.3×
- 0.84
- 43.9%
- 4.6×
- 0.83
- 0.83
- 0.14
How it ranks in Real Estate
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 24%of 746
Top 37%of 752
Bottom 33%of 666
Top 36%of 762
Top 37%of 763
What analysts expect
- Average price target
- $85.40
- Range
- $83.00 – $88.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 4, 2026 | 1.24 | 1.21 | +2.5% |
| Feb 26, 2026 | 1.22 | 0.80 | +52.3% |
| Nov 6, 2025 | 1.32 | 1.24 | +6.5% |
| Aug 6, 2025 | 1.22 | 1.16 | +5.2% |
| May 5, 2025 | 1.15 | 1.13 | +1.8% |
| Feb 25, 2025 | 1.13 | 1.10 | +2.7% |
| Nov 5, 2024 | 1.03 | 1.07 | −3.7% |
| Aug 6, 2024 | 1.18 | 1.10 | +7.3% |
5.0%of the share price, paid each year
On $1,000 invested$50a year at today's yield, before tax
−3.8%2020 to 2025
Raised1 yearin a row, in our data
Paid per share, each year
$3.40 in 2015 → $3.64 in 2025
How safe it looks
119.4% of its profit
Room to growStretchedMore than it earns: 71.7%
News
National Energy Services Reunited declares $0.10 dividendSeeking Alpha · Nov 10, 20263 US Defense Stocks Worth Watching As Nvidia Questions Hit National SecurityYahoo Finance · Nov 9, 2026Auburn National GAAP EPS of $0.72, revenue of $9.1MSeeking Alpha · Oct 27, 2026United CEO backs national wealth tax, inheritance leviesSeeking Alpha · Oct 20, 2026Butler National boosts share buyback authorization to $11.9MSeeking Alpha · Oct 7, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
52No pass
Benjamin Graham
54No pass
Philip Fisher
64Pass
Peter Lynch
47No pass
Joel Greenblatt
39No pass
Charlie Munger
54No pass
Terry Smith
54No pass
Questions about National Health Investors
Is National Health Investors a good stock to buy?
A business with weak numbers at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the National Health Investors AI analysis
What does National Health Investors do?
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It is in REIT - Healthcare Facilities, based in Murfreesboro, TN, United States, with 32 employees.
Does National Health Investors pay a dividend?
Yes. At today's price the dividend is 5.0% a year, about 119% of its yearly profit. In 2025 it paid out $170 million in dividends.
Is National Health Investors stock halal?
No. National Health Investors does not pass our halal screen: its debt is 36% of its market value, at or above the 33% limit. How we check
How has National Health Investors stock done over the past year?
Down 13.9% over the past twelve months, to $66.02. It traded between $63.96 and $91.02 and is 27.5% below its high.
Who are National Health Investors's competitors?
The largest listed companies in the same industry are Welltower, Ventas, Omega Healthcare Investors and Healthpeak Properties. The peers table on this page compares their profit, growth and price with National Health Investors's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.